Keytruda 200 mg (2 Vials)

Keytruda (Pembrolizumab) is a biological immunotherapy drug used to treat various types of cancer, including:
lung cancer, melanoma, bladder cancer, kidney cancer, gastric cancer, and some types of blood cancer.

It contains Pembrolizumab, a monoclonal antibody that helps the immune system target and destroy cancer cells by blocking the PD-1 receptor.

Key Features:
Immune checkpoint inhibitor for advanced cancers.

Boosts immune response to fight tumor cells.

Clinically proven efficacy in multiple cancers.

Can be used alone or in combination therapy.

Administration:
Typical dose: 200 mg (usually given every 3 or 6 weeks).

Route: Intravenous infusion under hospital supervision.

Kit includes: 2 vials, each containing 100 mg.

Warnings & Precautions:
Requires regular monitoring by oncology specialists.

May cause immune-related side effects such as fatigue, fever, rash, or changes in organ functions.

For hospital use only under medical supervision.

Storage:
Store in a refrigerator at 2–8°C (36–46°F).

Do not freeze.

Protect from light.

Keep out of reach of children.